CYTED LTD

Latest accounts filed cover 2024-12-31; financial figures currently reflect up to 2020-12-31.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Accounting basis

FRS 102 §1A

Reporting scope

Consolidated group

Abridged

Yes — abridged accounts (limited disclosure)

Auditor

RSM UK Audit LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Group has net current assets of £1,892,826. Therefore, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for at least 12 months following the signature of these financial statements which assume that no significant uncertainty could exist in respect of this decision. As part of the going concern assessment, sensitivities have been prepared against group forecasts to assess the impact on the business should current pipeline opportunities not be converted and/or additional funding is not secured. In this scenario, the business can undertake an expenditure review program to manage the necessary levers to maintain and/or reduce group expenditure where needed. The directors are confident that this can be implemented, without any material impact on existing customer contracts whilst ensuring the group will continue to settle its liabilities as and when they fall due. In the event that additional funding is not obtained, the convertible loan note holders could issue a redemption notice at the end of the term, on 1 February 2026. After the period end the holders have agreed to extend the term date to 1 February 2027, which removes the potential cash outflow outside of the going concern assessment. On this basis, the directors are satisfied that without future funding they have the ability and time to control spend where necessary, so it remains appropriate to prepare the financial statements on a going concern basis.”

Group structure

1. CYTED LTD · parent
   1. Cyted UK Ltd 100% · UK · Provision of digital diagnostic infrastructure
   2. Cyted Health Ltd 100% · UK · Provision of digital diagnostic infrastructure
   3. Cyted Health Inc 100% · US · Provision of digital diagnostic infrastructure

Significant events

• “In May 2025, the Company completed the sale of its subsidiary, Cyted UK Limited. The sale was finalised after the balance sheet date and is considered a non-adjusting event under FRS 102.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

20

last 12 months

Capital events

4

last 24 months

Officers appointed

3

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  +4,146.4%

  £45,600 → £1,936,374

• Net assets

  —

  Not reported

• Employees

  +166.7%

  3 → 8

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers